Anti-HA Affinity Gel -20586ES

SKU: 20586ES03

Size: 1mL
Price:
Sale price$460.00

Shipping calculated at checkout

Stock:
In stock

Description


Anti-HA Affinity Gel is prepared by conjugating high quality murine IgG1 monoclonal antibody with Sepharose 4B gel. This product has a high HA label fusion protein loading capacity (at least 1.5 mg protein/mL gel) and less non-specific binding of miscellaneous proteins. It can be used for immunoprecipitation (IP) and purification of fusion proteins with HA labels.

Features

  • Specific—highly specific monoclonal antibody
  • High yield and high purity
  • Versatile—It can be used for protein purification or COIP
  • Convenient—reagents and peptides to elute are available separately

Applications

  • Immunoprecipitation (IP)
  • Purification of fusion proteins with HA labels.

Specifications

Clone 1A4
Isotype Mouse IgG1
Purity Protein A
Antibody Concentration 7.5 g antibody/L Gel
Protein binding capacity ≥1.5 mg protein/mL Gel
Storage buffer 10 mM Na3PO4, 150 mM NaCl, 50% glycerin, pH7.4, contains 0.02% (w/v) sodium azide

Components

Components No. Name 20586ES03 20586ES08 20586ES25 20586ES60
20586 Anti-HA Affinity Gel 1 mL 5 mL 25 mL 100 mL

Storage

The unopened products should be stably stored at -25℃ ~ -15℃ for 1 year. Do not freeze in solution without glycerin!

Payment & Security

American Express Apple Pay Diners Club Discover Google Pay Mastercard Visa

Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

Inquiry

You may also like

FAQ

The product is for research purposes only and is not intended for therapeutic or diagnostic use in humans or animals. Products and content are protected by patents, trademarks, and copyrights owned by Yeasen Biotechnology. Trademark symbols indicate the country of origin, not necessarily registration in all regions.

Certain applications may require additional third-party intellectual property rights.

Yeasen is dedicated to ethical science, believing our research should address critical questions while ensuring safety and ethical standards.